A recent study suggests that patients who discontinue new slimming jabs like Wegovy and Mounjaro tend to recover shed pounds far faster than those who halt conventional lifestyle regimens.
Research printed in a prominent health publication points out that while overweight people frequently drop substantial amounts of their body weight while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month after stopping.
"Individuals buying such medications must be informed of the potential of quick rebound weight gain when the treatment ends," stated expert Dr. Susan Jebb.
This pace of recovery implies a return to starting mass in about a year and a half.
Weighing Treatments
The study, which looked at 37 of trials involving thousands of participants, compared the outcomes of these new drugs with older methods.
Researchers point out that individuals who lose weight through lifestyle changes alone generally experience a slower creep back—perhaps 0.1 kg a month—post-intervention.
The Reason for the Fast Rebound
Nutrition scientists suggest the mode of action of the jabs accounts for the heightened regain.
The injections copy a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of GLP-1 levels several times higher than normal could lead to the system to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication results in appetite is unsuppressed, making overeating a significant risk."
A Chronic Disease?
Medical guidelines suggest the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.
Many experts say that, considering the significant potential of weight regain, the treatment is often long-term.
This opinion is echoed by pharmaceutical companies, who state that the results "emphasize the chronic character of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
Users who have come off the medication explain a sudden return of cravings.
"I experienced a trigger that goes on and I was suddenly starving," said a patient.
This difficulty is worsened if individuals have not established lasting dietary or behavioural changes during therapy.
Widespread Use
Survey data suggest that a significant number of adults in the UK have used these injections in the last 12 months, with interest continuing to grow.
- Use is greater among females than males.
- The middle-aged age group shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
In conclusion, experts emphasize that while the jabs are powerful agents for weight loss, they are not a permanent cure and long-term success likely depends on ongoing behavioural management.
